Virbac Sa

Panmedica S.a.

Panmedica

S. A. Panmedica

Laboratoires Virbac

Laboratories Virbac

Laboratoires Ardeval

Bernard Raynier

Claude Laruelle

Marcel Lepant

Guy Derrieu

Jean-Luc Pougnas

Luc Castelli

Carolin L Schumacher

Andre Aubert

The invention relates to a self-emulsifiable liquid composition intended to be diluted in an aqueous intermediate solution and then incorporated into the drinking water of livestock animals, and also to the use of such a composition. The invention is characterized in that the composition comprises at least&#x2014;between 1% and 12% by weight of the florfenicol active ingredient, relative to the total volume of the composition; &#x2014;at least 50% by weight, relative to the total volume of the composition (p/v), of a mixture of C8-C10 saturated polyglycosylated glycerides having an HLB (hydrophilic-lipophilic balance) of less than 16; and&#x2014;at least 5% by weight, relative to the total volume of the composition (p/v), of a surfactant.

Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock

Composition and system for oral administration to animals

Orally-administered dosage form for animals, preparation method therefor

Stabilized pulverulent active agents, compositions containing them and also process for obtaining them; such stabilized active agents enable dry and stable pharmaceutical, dietary, nutritional or cosmetic compositions to be obtained, in which the properties of the said active agents are neither modified nor impaired. Such stabilized active agents are stabilized by coating with a coating composition comprising:

Stabilized pulverulent active agents, compositions containing them,

Solid compositions based on plants, capable of being converted to a dry and porous galenic form (lyophilized or equivalent form) which is undivided or powdered. Said dry and porous galenic form comprises a solid composition II consisting of a solid composition I composed of:

Dry and Porous galenic form based on plants, its method of preparation

Hydroquinone amino-acid esters, methods of preparation, and

Amino acid esters of cycloaliphatic alcohols of the formula: ##STR1## wherein A is cyclohexyl, cyclohexenyl, cyclopentyl, or cyclopentenyl, substituted with from one to three radicals selected from the group consisting of methyl, ethyl and ethenyl. These compounds are useful in treating lipemic disorders.

Amino acid esters of cycloaliphatic alcohols and their use in treating

Amino acid esters of cycloaliphatic alcohols of the formula: ##STR1## wherein A is cyclohexyl, cyclohexenyl, cyclopentyl and cyclopentenyl, substituted with from one to three radicals which are methyl, ethyl, and/or ethenyl. These amino acid esters have hypolipemic properties.

Amino acid of cycloaliphatic alcohols, process for their preparation and

Drugs with high anticonvulsant and analgesic activities constituted by symmetrical .beta.-dialkoxyiminocycloalklene derivatives in which the imine double bonds are conjugated with the cyclic double bond or bonds belonging to one or more fused benzene rings. They correspond to the general formula I: ##STR1##

Symmetrical O-substituted dioximes of benzo-fused

Alkylcarboxamides of pyridylalkylamines, useful in human and verterinary medicine, correspond to the general formula I: ##STR1## wherein n=0 or 1,

Alkylcarboxamides of pyridylalkylamines, and their use in human and

The present invention relates to novel antibacterial agents, corresponding to the following general formula I ##STR1## in which: Q represents an aromatic ring,

Antibacterial agents containing oxo-4-pyridine carboxylic acid

The present invention relates to new adamantanamine derivatives. These derivatives correspond to the general formula I: ##STR1## in which: R represents hydrogen or a substituted or unsubstituted, linear or branched alkyl radical containing from 1 to 7 carbon atoms. Drugs possessing anticonvulsant properties.

Adamantanamine derivatives, processes for their preparation and drugs in

The present invention relates to new N-acyl derivatives of amino acids. These derivatives correspond to the general formula I below: ##STR1## in which A represents a linear or branched, saturated hydrocarbon radical containing from 1 to 6 carbon atoms or a saturated ring containing 6 carbon atoms,

N-acyl derivatives of amino acids and their esters, and drugs in which

The present invention relates to new dipeptides of L-5-hydroxytryptophan. They correspond to the general formula below: ##STR1## in which: X represents hydrogen or a lower acyl radical and

Growing community of inventors

Nice, France

Bernard Raynier